Ligand to Participate in May Investor Conferences

Ligand (Nasdaq: LGND) will have senior management participate in multiple investor conferences in May 2026, including virtual and in-person events.

Rhea-AI Summary

Ligand (Nasdaq: LGND) will have senior management participate in multiple investor conferences in May 2026, including virtual and in-person events. Management will give fireside chats and host one-on-one meetings at H.C. Wainwright, Bank of America, CJS Securities, RBC, Craig-Hallum, Benchmark, and others.

Investors seeking one-on-one meetings should contact their conference or broker representative to arrange sessions.

Argus May 6 session

+0.11% close to close Open Argus

Details

News Market Reaction – LGND

In the May 6 session, LGND gained 0.11%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines an intensive May conference schedule, with multiple fireside chats and on...

Analysis

This announcement outlines an intensive May conference schedule, with multiple fireside chats and one-on-one meetings across major healthcare events. It follows a series of value-focused updates, including the XOMA Royalty acquisition and an FDA partner approval that previously coincided with gains of 4.55% and 8.85%, respectively. With shares trading above the 187.52 200-day MA and within 7.69% of the 52-week high, investors may watch how these meetings influence future corporate and partnership updates.

Key Figures

H.C. Wainwright chat time: 9:30 a.m. ET BofA chat time: 4:20 p.m. PT RBC chat time: 11:30 a.m. ET +5 more

H.C. Wainwright chat time

9:30 a.m. ET

Virtual Royalty Company Conference on May 6, 2026

BofA chat time

4:20 p.m. PT

Bank of America Healthcare Conference on May 12, 2026

RBC chat time

11:30 a.m. ET

RBC Capital Markets Global Healthcare Conference on May 20, 2026

Current price

$228.36

Price prior to May 5, 2026 conference announcement

52-week high

$247.38

52-week range prior to this news

52-week low

$98.89

52-week range prior to this news

Price vs 52-week high

-7.69%

Distance from 52-week high before this article

Price vs 52-week low

130.92%

Gain from 52-week low before this article

Historical Context

5 past events · Latest: Apr 27

5 events

1. Apr 27

   Royalty acquisition

   24h Move

   +4.5%

   Agreed to acquire XOMA Royalty and raised 2026 revenue and EPS guidance.

2. Apr 22

   Earnings date notice

   24h Move

   -0.1%

   Scheduled Q1 2026 results call and provided webcast and dial-in details.

3. Apr 14

   FDA approval

   24h Move

   +8.8%

   Partner Travere gained full FDA approval for FILSPARI with 9% royalty to Ligand.

4. Mar 26

   Team expansion

   24h Move

   -0.4%

   Announced senior hires and a promotion to strengthen business development team.

5. Mar 04

   Investor conferences

   24h Move

   +2.3%

   Outlined March 2026 conference appearances and one-on-one meeting availability.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

JUPITER, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences:

• H.C. Wainwright Royalty Company Conference (Virtual): Ligand CEO Todd Davis and Wes Kaupinen, president and CEO of Ligand portfolio company Palvella Therapeutics, will participate in a fireside chat at 9:30 a.m. ET on May 6, 2026.
  
• Bank of America Healthcare Conference (Las Vegas): Management will participate in a fireside chat at 4:20 p.m. PT on May 12, 2026 and be available for one-on-one meetings on May 12, 2026 and May 13, 2026.
  
• CJS Securities Spring 1x1 Conference (Virtual): Management will participate in one-on-one meetings on May 13, 2026.
  
• H.C. Wainwright BioConnect Investor Conference at Nasdaq (New York): Management will participate in a fireside chat at 9:30 a.m. ET on May 19, 2026 and be available for one-on-one meetings.
  
• RBC Capital Markets Global Healthcare Conference (New York): Management will participate in a fireside chat at 11:30 a.m. ET on May 20, 2026.
  
• Craig-Hallum Institutional Investor Conference (Minneapolis): Management will participate in one-on-one meetings on May 28, 2026.
  
• Benchmark Healthcare House Call Conference (Virtual): Management will participate in one-on-one meetings on May 28, 2026.
  
  

Ligand management is scheduled to host one-on-one meetings with investors and attendees during these conferences. Investors interested in arranging one-on-one meetings should contact their Bank of America, Benchmark, CJS Securities, Craig-Hallum, H.C. Wainwright, or RBC representative.

About Ligand
Ligand is a leading royalty aggregator, partnering with biopharmaceutical companies to finance and advance late-stage clinical development programs. Ligand owns and manages one of the largest and most diversified portfolios of biopharmaceutical royalties in the industry, with economic interests in more than 100 development and commercial-stage assets. Ligand funds high-value programs in exchange for long-term economic interests, aligning capital with clinical and commercial success. Ligand’s royalty portfolio is designed to deliver consistent and predictable revenue streams across a broad range of therapeutic assets. Ligand also licenses its proprietary technologies, Captisol^® and NITRICIL™, to support drug development and formulation across its global partner network. For more information, visit www.ligand.com or follow Ligand on X and LinkedIn.

Contacts
Investors:
Melanie Herman
investors@ligand.com
(858) 550-7761

Media:
Kellie Walsh
media@ligand.com
(914) 315-6072

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Ligand (LGND) present at the Bank of America Healthcare Conference in May 2026?

Ligand will present at 4:20 p.m. PT on May 12, 2026 with one-on-one meetings available May 12–13. According to the company, management will participate in a fireside chat and schedule investor meetings through Bank of America representatives.

How can investors arrange one-on-one meetings with Ligand (LGND) management at May 2026 conferences?

Investors should contact their conference or broker representative to arrange meetings. According to the company, one-on-one meetings are coordinated via Bank of America, Benchmark, CJS Securities, Craig-Hallum, H.C. Wainwright, or RBC representatives.

Which Ligand (LGND) executives will appear at the H.C. Wainwright Royalty Company virtual event on May 6, 2026?

Ligand CEO Todd Davis will appear with Palvella CEO Wes Kaupinen in a fireside chat at 9:30 a.m. ET on May 6, 2026. According to the company, this event is virtual and part of their May investor schedule.

What events will Ligand (LGND) attend the week of May 18–20, 2026?

Management will appear at H.C. Wainwright BioConnect on May 19 and RBC Global Healthcare on May 20 with fireside chats both days. According to the company, they will also be available for one-on-one meetings during those conferences.

Is Ligand (LGND) offering virtual and in-person meetings at May 2026 investor conferences?

Yes. Ligand will participate in virtual fireside chats and in-person conferences with one-on-one meetings across May 2026. According to the company, events include virtual sessions and in-person appearances in Las Vegas, New York, and Minneapolis.